Saturday Edition
Stay updated with Archyde – your source for breaking news, global headlines, economy, entertainment, health, technology, and sports. Fresh stories daily.
Exagamglogene autotemcel (exa-cel), a CRISPR/Cas9 gene-editing therapy, has demonstrated sustained efficacy in children with transfusion-dependent β-thalassemia and sickle cell disease, according to new data published in the New England Journal ... Read More
Continuous Coverage
Raytheon’s “software factory” is accelerating U.S. Navy ship upgrades using RTX, a real-time operating system (RTOS) built on…
Haley Simmons, a student at the University of Nevada, Reno (UNR) Orvis School of Nursing, has developed an…
Japanese social media users and copyright advocates are expressing widespread indignation over the use of AI-generated imagery mimicking…
University of Oklahoma junior Jalen Stringfellow closed his first season as a Sooner with a 7.24m (23’9.00″) long…
SpaceX’s Starlink Satellites Trigger Unintended Atmospheric Effects, Study Reveals SpaceX’s Starlink satellite constellation, launched to provide global broadband,…
Transurban (ASX: TCL) has launched a fuel rebate program for Linkt account holders, offering a 26-cent-per-litre discount at…
Global Affairs
A Latvian ice hockey player accidentally shot his grandfather with a hunting rifle on Tuesday, June 4, in…
Markets And Money
Major Peruvian family-owned conglomerates, including Intercorp (BVL: INTERCORC1) and Alicorp (BVL: ALICORP), are aggressively expanding their footprint in…
Digital Culture
Ahmad Torkmany, a final-year student at the CFP Arts in Geneva, won the 4th edition of the Bucherer…
Science And Wellbeing
Modern human aging rates are increasingly viewed through an evolutionary “disposable soma” lens, which posits that organisms prioritize…
Screen And Sound
Cape Town has been crowned the world’s No. 1 city for food in 2026 by Time Out, vaulting…
Fixtures And Form
Liverpool winger Rio Ngumoha’s reported dissatisfaction amid Arne Slot’s exit has intensified speculation about his future, with Bayern…
